Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY01005 vs Goserelin depot in prostate cancer
CTR20192720Phase 3Completed
- Sponsor
- Luye Pharma Group
- Start
- Jan 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Baituowei in prostate cancer (PCa), sponsored by Luye Pharma Group. Started Jan 2020; status: completed.
02
Drugs
Baituowei
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20192720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192720.